These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 8913243

  • 1. Preliminary results of combined chemotherapy and radiotherapy for non-AIDS primary central nervous system lymphoma. Trans-Tasman Radiation Oncology Group (TROG).
    O'Brien PC, Roos DE, Liew KH, Trotter GE, Barton MB, Walker QJ, Poulsen MG, Olver IN.
    Med J Aust; 1996 Oct 21; 165(8):424-7. PubMed ID: 8913243
    [Abstract] [Full Text] [Related]

  • 2. Combined-modality therapy for primary central nervous system lymphoma: long-term data from a Phase II multicenter study (Trans-Tasman Radiation Oncology Group).
    O'Brien PC, Roos DE, Pratt G, Liew KH, Barton MB, Poulsen MG, Olver IN, Trotter GE, Trans-Tasman Radiation Oncology Group.
    Int J Radiat Oncol Biol Phys; 2006 Feb 01; 64(2):408-13. PubMed ID: 16198065
    [Abstract] [Full Text] [Related]

  • 3. High-dose methotrexate-based chemotherapy followed by consolidating radiotherapy in non-AIDS-related primary central nervous system lymphoma: European Organization for Research and Treatment of Cancer Lymphoma Group Phase II Trial 20962.
    Poortmans PM, Kluin-Nelemans HC, Haaxma-Reiche H, Van't Veer M, Hansen M, Soubeyran P, Taphoorn M, Thomas J, Van den Bent M, Fickers M, Van Imhoff G, Rozewicz C, Teodorovic I, van Glabbeke M, European Organization for Research and Treatment of Cancer Lymphoma Group.
    J Clin Oncol; 2003 Dec 15; 21(24):4483-8. PubMed ID: 14597741
    [Abstract] [Full Text] [Related]

  • 4. Primary central nervous system lymphoma: Phase I evaluation of infusional bromodeoxyuridine with whole brain accelerated fractionation radiation therapy after chemotherapy.
    Dabaja BS, McLaughlin P, Ha CS, Pro B, Meyers CA, Seabrooke LF, Wilder RB, Kyritsis AP, Preti HA, Yung WK, Levin V, Cabanillas F, Cox JD.
    Cancer; 2003 Sep 01; 98(5):1021-8. PubMed ID: 12942571
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Response to chemotherapy and treating institution predict survival in primary central nervous system lymphoma.
    Korfel A, Martus P, Nowrousian MR, Hossfeld DK, Kirchen H, Brücher J, Stelljes M, Birkmann J, Peschel C, Pasold R, Fischer L, Jahnke K, Thiel E, German primary central nervous system lymphoma Study Group (G-PCNSL-SG).
    Br J Haematol; 2005 Jan 01; 128(2):177-83. PubMed ID: 15638851
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Long-term survival following radiotherapy and cytarabine chemotherapy for sporadic primary central nervous system lymphoma.
    Pöttgen C, Stuschke M, Stüben G, Schmitz A, Schwechheimer K, Wacker HH, Rauhut F, Kleuker S, Wilhelm H, Grehl S, Fehlings T.
    Strahlenther Onkol; 2003 Sep 01; 179(9):626-32. PubMed ID: 14628129
    [Abstract] [Full Text] [Related]

  • 12. Primary central nervous system lymphoma: monocenter, long-term, intent-to-treat analysis.
    Kiewe P, Fischer L, Martus P, Thiel E, Korfel A.
    Cancer; 2008 Apr 15; 112(8):1812-20. PubMed ID: 18318432
    [Abstract] [Full Text] [Related]

  • 13. Modified ProMACE-MOPP hybrid regimen with moderate-dose methotrexate for patients with primary CNS lymphoma.
    Yamanaka R, Morii K, Shinbo Y, Takeuchi S, Tamura T, Hondoh H, Takahashi H, Onda K, Takahashi H, Tanaka R.
    Ann Hematol; 2005 Jul 15; 84(7):447-55. PubMed ID: 15747120
    [Abstract] [Full Text] [Related]

  • 14. Cognitive outcomes and long-term follow-up results after enhanced chemotherapy delivery for primary central nervous system lymphoma.
    McAllister LD, Doolittle ND, Guastadisegni PE, Kraemer DF, Lacy CA, Crossen JR, Neuwelt EA.
    Neurosurgery; 2000 Jan 15; 46(1):51-60; discussion 60-1. PubMed ID: 10626935
    [Abstract] [Full Text] [Related]

  • 15. Combined immunochemotherapy with reduced whole-brain radiotherapy for newly diagnosed primary CNS lymphoma.
    Shah GD, Yahalom J, Correa DD, Lai RK, Raizer JJ, Schiff D, LaRocca R, Grant B, DeAngelis LM, Abrey LE.
    J Clin Oncol; 2007 Oct 20; 25(30):4730-5. PubMed ID: 17947720
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Treatment of central nervous system malignant lymphoma].
    Nakamura O.
    No To Shinkei; 2005 Dec 20; 57(12):1043-9. PubMed ID: 16375189
    [No Abstract] [Full Text] [Related]

  • 18. Long-term follow-up of high-dose methotrexate-based therapy with and without whole brain irradiation for newly diagnosed primary CNS lymphoma.
    Gavrilovic IT, Hormigo A, Yahalom J, DeAngelis LM, Abrey LE.
    J Clin Oncol; 2006 Oct 01; 24(28):4570-4. PubMed ID: 17008697
    [Abstract] [Full Text] [Related]

  • 19. Treatment of relapsed central nervous system lymphoma with high-dose methotrexate.
    Plotkin SR, Betensky RA, Hochberg FH, Grossman SA, Lesser GJ, Nabors LB, Chon B, Batchelor TT.
    Clin Cancer Res; 2004 Sep 01; 10(17):5643-6. PubMed ID: 15355887
    [Abstract] [Full Text] [Related]

  • 20. [High-dose methotrexate followed by whole-brain irradiation for primary central nervous system lymphoma patients--a retrospective study in a single institute].
    Usui N, Dobashi N, Yano S, Yahagi Y, Takei Y, Otsubo H, Takahara S, Yamaguchi Y, Saito T, Minami J, Kamiyama Y, Morikawa N, Machishima T, Osawa H, Aiba K.
    Gan To Kagaku Ryoho; 2010 Jul 01; 37(7):1277-82. PubMed ID: 20647709
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.